Sale!

RBCK1 Gene Polyglucosan Body Myopathy Type 1 with or Without Immunodeficiency Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

RBCK1 Gene Polyglucosan Body Myopathy Type 1 with or without Immunodeficiency is a rare genetic disorder characterized by the accumulation of polyglucosan bodies in muscle and nerve cells, leading to muscle weakness and, in some cases, immunodeficiency. The condition is caused by mutations in the RBCK1 gene, which plays a crucial role in the immune response and muscle function.

DNA Labs UAE offers a genetic test to diagnose this condition by analyzing the RBCK1 gene for mutations. This test is crucial for individuals showing symptoms of the disorder or those with a family history of the condition, as it can confirm the diagnosis and help in managing the symptoms effectively.

The cost of the RBCK1 Gene Polyglucosan Body Myopathy Type 1 with or Without Immunodeficiency Genetic Test at DNA Labs UAE is 4400 AED. This test is performed with a high level of accuracy, utilizing advanced genetic sequencing technologies to detect mutations in the RBCK1 gene. The result from this test can provide essential information for the patient’s healthcare provider to devise an appropriate treatment and management plan, potentially improving the quality of life for affected individuals.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

RBCK1 Gene Polyglucosan body myopathy type 1 with or without immunodeficiency Genetic Test

Test Name: RBCK1 Gene Polyglucosan body myopathy type 1 with or without immunodeficiency Genetic Test

Components: Price 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test type: Neurological Disorders

Doctor: Neurologist

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for RBCK1 Gene Polyglucosan body myopathy type 1 with or without immunodeficiency NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with RBCK1 Gene Polyglucosan body myopathy type 1 with or without immunodeficiency

Test Details: The RBCK1 gene is associated with a condition called polyglucosan body myopathy type 1 with or without immunodeficiency. This is a genetic disorder characterized by muscle weakness and wasting, as well as an increased risk of infections due to immune system dysfunction. The NGS genetic test refers to Next-Generation Sequencing, which is a high-throughput method used to analyze multiple genes simultaneously. This type of genetic testing can identify mutations or variations in the RBCK1 gene that may be responsible for the development of polyglucosan body myopathy type 1 with or without immunodeficiency. By performing an NGS genetic test, healthcare professionals can determine if a person has mutations in the RBCK1 gene, which can help with diagnosis and provide important information for treatment and management of the condition.

Test Name RBCK1 Gene Polyglucosan body myopathy type 1 with or without immunodeficiency Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for RBCK1 Gene Polyglucosan body myopathy type 1 with or without immunodeficiency NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with RBCK1 Gene Polyglucosan body myopathy type 1 with or without immunodeficiency
Test Details

The RBCK1 gene is associated with a condition called polyglucosan body myopathy type 1 with or without immunodeficiency. This is a genetic disorder characterized by muscle weakness and wasting, as well as an increased risk of infections due to immune system dysfunction.

The NGS genetic test refers to Next-Generation Sequencing, which is a high-throughput method used to analyze multiple genes simultaneously. This type of genetic testing can identify mutations or variations in the RBCK1 gene that may be responsible for the development of polyglucosan body myopathy type 1 with or without immunodeficiency.

By performing an NGS genetic test, healthcare professionals can determine if a person has mutations in the RBCK1 gene, which can help with diagnosis and provide important information for treatment and management of the condition.